TABLE 3.

Associations of baseline physical activity, cardiorespiratory fitness, and body composition with follow-up menopausal symptoms in the longitudinal study (n = 82)

	Total symptoms		Somato-vegetative symptoms		Psychological symptoms		Urogenital symptoms
	B	95% CI	B	95% CI	B	95% CI	B	95% CI
ACC-PA (10 mg)	−0.18	−1.08 to 0.72	−0.13	−0.55 to 0.29	0.03	−0.38 to 0.44	−0.08	−0.43 to 0.27
SR-PA (MET-h/d)	−0.01	−0.19 to 0.18	0.01	−0.08 to 0.10	0.00	−0.08 to 0.08	−0.01	−0.09 to 0.06
Predicted VO2max (l/min)a	−2.06	−7.23 to 3.12	−1.12	−3.63 to 1.39	−0.56	−2.84 to 1.71	−0.37	−2.40 to 1.67
Total body mass (kg)b	−0.03	−0.13 to 0.06	−0.03	−0.07 to 0.02	0.01	−0.03 to 0.05	−0.02	−0.05 to 0.02
Body fat mass (kg)b	−0.04	−0.39 to 0.31	0.01	−0.16 to 0.17	−0.05	−0.20 to 0.10	0.01	−0.13 to 0.14
Lean body mass (kg)b	0.04	−0.29 to 0.37	0.00	−0.16 to 0.16	0.06	−0.09 to 0.20	−0.02	−0.15 to 0.11

Multiple imputation was applied in the analyses. All models are adjusted with baseline menopausal status, age, use of hormonal preparations, smoking, education, and alcohol consumption.

ACC-PA, accelerometer-measured physical activity mean amplitude deviation; mg, milligravity (0.00981 m/s²); SR-PA, self-reported physical activity; VO_2max, maximal oxygen consumption.

^aModel is additionally adjusted with baseline lean body mass.

^bModel is additionally adjusted with baseline body height.